NFE2L2 and diabetes mellitus: Both the WT and the Nrf2 KO diabetic mice developed significantly higher blood glucose levels at 0, 4, 8, 12, 16, 20, and 24 weeks post diabetes onset, as compared with respective controls (Figures 1(a) and 1(b)).